Lung fluid clearance in chronic heart failure patients

Area of Science:

• Pulmonary medicine
• Cardiology
• Physiology

Background:

• Chronic elevation of pulmonary microvascular pressure (Pmv) causes alveolocapillary barrier thickening.
• Despite high hydrostatic pressure in chronic heart failure (CHF), lungs remain dry, suggesting enhanced fluid clearance mechanisms.
• Bi-directional fluid flux is key, with increased alveolar fluid clearance potentially mitigating pulmonary edema.

Purpose of the Study:

• To investigate alveolar fluid clearance in ambulatory patients with CHF due to left ventricular systolic dysfunction.
• To compare alveolar fluid clearance between CHF patients and non-CHF controls.
• To explore the relationship between alveolar fluid clearance and CHF severity.

Main Methods:

• Aerosolized 99mTc-diethyl triaminepentaacetic acid (DTPA) was used to measure lung clearance.
• Non-invasive scintigraphy assessed the half-time of 99mTc-DTPA clearance (T1/2).
• Alveolar fluid clearance was calculated using mono-exponential curve fitting.

Main Results:

• Alveolar fluid clearance, indicated by T1/2 DTPA clearance, was significantly faster in CHF patients compared to controls (P=0.001).
• Clearance rates correlated with NYHA classification, suggesting increased clearance with disease severity.
• No correlation was observed between DTPA clearance and plasma levels of epinephrine, norepinephrine, or aldosterone.

Conclusions:

• Alveolar fluid clearance is increased in patients with CHF.
• This enhanced clearance is associated with CHF severity.
• Increased alveolar fluid clearance may represent a compensatory lung defense mechanism against pulmonary edema in CHF.